Valuation: BOIRON

Market Cap 490M 558M 451M 423M 792M 52.68B 809M 5.42B 2.1B 26.03B 2.1B 2.05B 90.27B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 442M 504M 407M 381M 715M 47.53B 730M 4.89B 1.89B 23.49B 1.89B 1.85B 81.45B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+3.30%
Current month+0.71%
1 month+2.92%
3 months+11.90%
6 months-6.00%
Current year-5.84%
1 week 27
Extreme 27
28.5
1 month 26.5
Extreme 26.5
29
3 years 20.7
Extreme 20.7
55.3
5 years 20.7
Extreme 20.7
55.3
10 years 20.7
Extreme 20.7
92.03
Manager TitleAgeSince
Chief Executive Officer 56 31/12/2024
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Chairman 65 30/06/2011
Director/Board Member 54 09/03/2010
Director/Board Member 51 22/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%+3.30%+28.18%-26.56% 558M
-0.32%-2.95%-15.89%-9.30% 12.33B
-2.14%-4.72%-38.81%-59.87% 4.51B
-0.57%-4.82%-17.28%-10.97% 4.11B
-3.74%-2.40%+4.56%-42.35% 3.6B
-3.92%-6.18%+6.51%-20.53% 3.58B
-1.01%-1.97%-12.32%-11.10% 3.44B
-2.50%-6.03%-15.56%-6.03% 2.91B
-4.14%-5.96%-11.08%-28.36% 2.23B
0.00%-3.73%-14.63%+22.05% 1.6B
Average -2.04%-3.70%-8.63%-19.30% 4.26B
Weighted average by Cap. -1.66%-3.69%-13.44%-19.41%

Financials

2024 2025
Net sales 488M 556M 449M 421M 789M 52.46B 805M 5.4B 2.09B 25.92B 2.09B 2.04B 89.89B 501M 572M 462M 432M 811M 53.91B 828M 5.55B 2.15B 26.64B 2.15B 2.1B 92.39B
Net income 11.34M 12.93M 10.45M 9.78M 18.34M 1.22B 18.72M 126M 48.6M 603M 48.55M 47.49M 2.09B 32.64M 37.23M 30.09M 28.17M 52.82M 3.51B 53.92M 362M 140M 1.74B 140M 137M 6.02B
Net Debt -49.74M -56.73M -45.85M -42.92M -80.49M -5.35B -82.16M -551M -213M -2.64B -213M -208M -9.17B -47.86M -54.58M -44.11M -41.3M -77.44M -5.15B -79.05M -530M -205M -2.54B -205M -200M -8.82B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
29/06/26 27.80 -1.42%
26/06/26 €28.20 +2.17%
25/06/26 €27.60 +0.73%
24/06/26 €27.40 -1.79%
23/06/26 €27.90 +1.82%

Annual profits - Rate of surprise